Cannara Biotech Inc (LOVE.V)
0.75
-0.03
(-3.85%)
CAD |
TSXV |
May 27, 15:58
Cannara Biotech Shareholders Equity (Quarterly): 79.34M for Feb. 29, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 79.34M |
| November 30, 2023 | 81.86M |
| August 31, 2023 | 79.74M |
| May 31, 2023 | 74.98M |
| February 28, 2023 | 71.77M |
| November 30, 2022 | 67.28M |
| August 31, 2022 | 66.74M |
| May 31, 2022 | 64.18M |
| February 28, 2022 | 62.54M |
| November 30, 2021 | 63.52M |
| August 31, 2021 | 64.12M |
| Date | Value |
|---|---|
| May 31, 2021 | 36.50M |
| February 28, 2021 | 34.23M |
| November 30, 2020 | 35.03M |
| August 31, 2020 | 38.36M |
| May 31, 2020 | 39.41M |
| February 29, 2020 | 41.51M |
| November 30, 2019 | 44.70M |
| August 31, 2019 | 47.16M |
| May 31, 2019 | 47.40M |
| February 28, 2019 | 46.48M |
| November 30, 2018 | 0.021M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
34.23M
Minimum
Feb 2021
81.86M
Maximum
Nov 2023
57.02M
Average
63.03M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biocure Technology Inc | 1.603M |
| Core One Labs Inc | 5.641M |
| Nova Mentis Life Science Corp | -0.601M |
| Nanosphere Health Sciences Inc | -2.064M |
| Lobe Sciences Ltd | -1.235M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.82M |
| Total Liabilities (Quarterly) | 66.48M |
| Debt to Equity Ratio | 0.6136 |
| Current Ratio | 0.969 |
| Net Debt Paydown Yield | -0.15% |